Intelligence · Clinical Development
Pipeline search results
Programs matching “Vertex Pharmaceuticals” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 159 pipeline programs matching "Vertex Pharmaceuticals" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Placebo
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Healthy Volunteers
1 trial -
Prednisone
Vertex Pharmaceuticals (Australia) Pty.
Drug Interactions
1 trial -
SUZ
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Healthy Participants
1 trial -
Telaprevir; Moxifloxacin; Placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Treatment sequence AB
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VCH 916
Vertex Pharmaceuticals (Australia) Pty.
HCV Infection
1 trial -
VCH-222
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VX-118
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-147
Vertex Pharmaceuticals (Australia) Pty.
Focal Segmental Glomerulosclerosis (FSGS)
1 trial -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
VX-272
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-433
Vertex Pharmaceuticals (Australia) Pty.
Narcolepsy Type 1 (NT1)
1 trial -
VX-440
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-509
Vertex Pharmaceuticals (Australia) Pty.
Healthy
1 trial -
VX-548
Vertex Pharmaceuticals (Australia) Pty.
Pain
7 trials -
VX-581
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX-634
Vertex Pharmaceuticals (Australia) Pty.
Alpha 1-Antitrypsin Deficiency
1 trial -
VX-668
Vertex Pharmaceuticals (Australia) Pty.
Alpha-1 Antitrypsin Deficiency
1 trial -
VX-708
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
VX-708
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
1 trial -
VX-770
Vertex Pharmaceuticals (Australia) Pty.
In Development for Cystic Fibrosis
2 trials -
VX-828
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.